Back to Journals » OncoTargets and Therapy » Volume 6

Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities

Total article views   HTML views PDF downloads Totals
11,105 Dovepress* 8,593+ 1,763 10,356
PubMed Central* 2,512 1,206 3,718
Totals 11,105 2,969 14,074
*Since 24 July 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar